Literature DB >> 83301

Demonstration of shared and unique immunological determinants in enterotoxins from Vibrio cholerae and Escherichia coli.

J D Clements, R A Finkelstein.   

Abstract

Immunodiffusion and biological neutralization studies demonstrated that the heat-labile enterotoxin (LT) from Escherichia coli has antigenic determinants in common with each of the isolated subunits (A and B) of the enterotoxin (choleragen) from Vibrio cholerae. Each of the enterotoxins also possesses unique antigenic specificities. Monospecific antiserum to LT was prepared by immunization with antigens derived by immune precipitation of E. coli cell-free supernatant with isolated specific anticholeragenoid antibodies. This antiserum neutralized the biological acitivity of both LT and cholera enterotoxin and recognized antigens of both in immunodiffusion. This antiserum was adsorbed with choleragenoid to remove antibodies directed against the shared "B" immunological determinants. The neutralizing effect of the antiserum on cholera toxin was completely removed, but the neutralizing activity against the E. coli preparations was retained, although somewhat reduced. Antisera to the isolated subunits (A and B) of cholera enterotoxin neutralized the biological activity of cholera enterotoxin and LT. These antisera also recognized the homologous and heterologous antigens in immunodiffusion. Multiple forms or conformations of LT and its components may explain the diversity of the properties which have been reported for it.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 83301      PMCID: PMC422217          DOI: 10.1128/iai.22.3.709-713.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Subunit structure and N-terminal amino acid sequence of the three chains of cholera enterotoxin.

Authors:  D G Klapper; R A Finkelstein; J D Capra
Journal:  Immunochemistry       Date:  1976-07

4.  Immunologic cross-reactions of enterotoxins from Escherichia coli and Vibrio cholerae.

Authors:  N W Smith; R B Sack
Journal:  J Infect Dis       Date:  1973-02       Impact factor: 5.226

5.  Relationships among heat-labile enterotoxins of Escherichia coli and Vibrio cholerae.

Authors:  C L Gyles
Journal:  J Infect Dis       Date:  1974-03       Impact factor: 5.226

6.  Standardization of the chloramine-T method of protein iodination.

Authors:  R Hunter
Journal:  Proc Soc Exp Biol Med       Date:  1970-03

7.  Immunological interrelationships between cholera toxin and the heat-labile and heat-stable enterotoxins of coliform bacteria.

Authors:  F A Klipstein; R F Engert
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

8.  Immunological study of the heat-labile enterotoxins of Escherichia coli and Vibrio cholerae.

Authors:  C L Gyles
Journal:  Infect Immun       Date:  1974-03       Impact factor: 3.441

9.  Monospecific equine antiserum against cholera exo-enterotoxin.

Authors:  R A Finkelstein
Journal:  Infect Immun       Date:  1970-12       Impact factor: 3.441

10.  Escherichia coli enterotoxin-induced steroidogenesis in cultured adrenal tumor cells.

Authors:  C N Kwan; R M Wishnow
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

View more
  53 in total

1.  Phenotypic diversity of enterotoxigenic Escherichia coli strains from a community-based study of pediatric diarrhea in periurban Egypt.

Authors:  L F Peruski; B A Kay; R A El-Yazeed; S H El-Etr; A Cravioto; T F Wierzba; M Rao; N El-Ghorab; H Shaheen; S B Khalil; K Kamal; M O Wasfy; A M Svennerholm; J D Clemens; S J Savarino
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

2.  Cistrons encoding Escherichia coli heat-labile toxin.

Authors:  W S Dallas; D M Gill; S Falkow
Journal:  J Bacteriol       Date:  1979-09       Impact factor: 3.490

3.  Properties of homogeneous heat-labile enterotoxin from Escherichia coli.

Authors:  J D Clements; R J Yancey; R A Finkelstein
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

4.  Construction of a bifunctional Escherichia coli heat-stable enterotoxin (STb)-alkaline phosphatase fusion protein.

Authors:  R G Urban; L A Dreyfus; S C Whipp
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

5.  Escherichia coli heat-labile enterotoxin genes are flanked by repeated deoxyribonucleic acid sequences.

Authors:  T Yamamoto; T Yokota
Journal:  J Bacteriol       Date:  1981-02       Impact factor: 3.490

Review 6.  New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

Authors:  M M Levine; J B Kaper; R E Black; M L Clements
Journal:  Microbiol Rev       Date:  1983-12

7.  Protection against colibacillosis in neonatal piglets by immunization of dams with procholeragenoid.

Authors:  E Fürer; S J Cryz; F Dorner; J Nicolet; M Wanner; R Germanier
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

8.  Molecular cloning of Vibrio cholerae enterotoxin genes in Escherichia coli K-12.

Authors:  G D Pearson; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

9.  The expression of biologically active cholera toxin in Escherichia coli.

Authors:  M L Gennaro; P J Greenaway; D A Broadbent
Journal:  Nucleic Acids Res       Date:  1982-08-25       Impact factor: 16.971

10.  Automatic and manual latex agglutination tests for measurement of cholera toxin and heat-labile enterotoxin of Escherichia coli.

Authors:  T Ito; S Kuwahara; T Yokota
Journal:  J Clin Microbiol       Date:  1983-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.